Re-treatment 225Ac-J591 for mCRPC
NCT04576871
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
225Ac-J591
Sponsor
Weill Medical College of Cornell University